Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Akero Therapeutics (AKRO) Stock Price & Analysis
250 Followers
AKRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.52 - $54.88
Previous Close$38.32
Volume151.56K
Average Volume (3M)597.22K
Market Cap
$1.91B
Enterprise Value$1.83B
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)-13.1
Beta-0.88
Next Earnings
May 17, 2023EPS Estimate
-$0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.93
Shares Outstanding46,970,989
10 Day Avg. Volume826,625
30 Day Avg. Volume597,216
Standard Deviation0.32
R-Squared0.03
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)5.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-19.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$61.75Price Target Upside54.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Akero Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AKRO FAQ
What was Akero Therapeutics Inc’s price range in the past 12 months?
Akero Therapeutics Inc lowest stock price was $7.52 and its highest was $54.88 in the past 12 months.
What is Akero Therapeutics Inc’s market cap?
Currently, no data Available
When is Akero Therapeutics Inc’s upcoming earnings report date?
Akero Therapeutics Inc’s upcoming earnings report date is May 17, 2023 which is in 49 days.
How were Akero Therapeutics Inc’s earnings last quarter?
Akero Therapeutics Inc released its earnings results on Mar 17, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.783 by $0.293.
Is Akero Therapeutics Inc overvalued?
According to Wall Street analysts Akero Therapeutics Inc’s price is currently Undervalued.
Does Akero Therapeutics Inc pay dividends?
Akero Therapeutics Inc does not currently pay dividends.
What is Akero Therapeutics Inc’s EPS estimate?
Akero Therapeutics Inc’s EPS estimate is -$0.7.
How many shares outstanding does Akero Therapeutics Inc have?
Akero Therapeutics Inc has 46,970,990 shares outstanding.
What happened to Akero Therapeutics Inc’s price movement after its last earnings report?
Akero Therapeutics Inc reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.783. Following the earnings report the stock price went up 1.233%.
Which hedge fund is a major shareholder of Akero Therapeutics Inc?
Among the largest hedge funds holding Akero Therapeutics Inc’s share is Baker Bros Advisors LP. It holds Akero Therapeutics Inc’s shares valued at 130M.
---
Akero Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$61.75 (54.61% Upside)
$61.75 (54.61% Upside)
Blogger Sentiment
Neutral
AKRO Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
162.10%
12-Months-Change
Fundamentals
Return on Equity
-45.20%
Trailing 12-Months
Asset Growth
82.34%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Akero Therapeutics Inc
Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding AKRO
Simplify Propel Opportunities ETF
Fidelity Nasdaq Composite Index ETF
Vanguard ESG U.S. Stock ETF
Dimensional US Core Equity Market ETF
Up to five ETFs with an Outperform Smart Score that hold AKRO. The ETFs are listed according to market value of AKRO within the ETF
---
ACADIA Pharmaceuticals
―
BioCryst
―
SAGE Therapeutics
―
Arcus Biosciences
―
Relay Therapeutics
―
---